<DOC>
	<DOC>NCT02967094</DOC>
	<brief_summary>Study was designed to evaluate efficacy of mucolytic solution ingested before upper endoscopy on visibility of gastric mucosa.</brief_summary>
	<brief_title>Mucolytic Solution Before Upper Endoscopy</brief_title>
	<detailed_description>Residual gastric content containing mucus, bubbles, bile and food particles may limit visibility of gastric mucosa and therefore diagnostic yield of upper endoscopy, especially in cases of early neoplastic lesions. Data on benefit of peroral mucolytic solution administered before upper endoscopy are limited.</detailed_description>
	<mesh_term>Stomach Neoplasms</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Expectorants</mesh_term>
	<criteria>age &gt; 18 years signed informed consent diagnostic gastroscopy age &lt; 18 years interventional gastroscopy known disease of the upper GI tract and/or history of surgery of GI tract gastroscopy indicated of bleeding, dysphagia or ileus liver cirrhosis general anesthesia</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>